Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 11, 2016, Pages 3058-3061

  Guérin, François ^a,b,c   Isnard, Christophe ^a,b   Sinel, Clara ^a   Morand, Philippe ^d   Dhalluin, Anne ^a   Cattoir, Vincent ^a,b,c   Giard, Jean Christophe ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c Centre National de Référence sur la Résistance aux Antibiotiques   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC HETERORESISTANCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM MUTANT; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTER CLOACAE COMPLEX; EPSILOMETER TEST; MICROBIAL POPULATION DYNAMICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPERON; PHENOTYPE; CLASSIFICATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; GENE DELETION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; GENE DELETION; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84994536179     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw260     Document Type: Article

References (22)

1. Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol 2012; 7: 887-902.
2. Morand PC, Billoet A, Rottman M et al. Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J Clin Microbiol 2009; 47: 2489-95.
3. Guérin F, Isnard C, Cattoir V et al. Complex regulation pathways of AmpC-mediated b-lactam resistance in Enterobacter cloacae complex. Antimicrob Agents Chemother 2015; 59: 7753-61.
4. Guérin F, Lallement C, Isnard C et al. Landscape of resistancenodulation-cell division (RND)-type efflux pumps in Enterobacter cloacae complex. Antimicrob Agents Chemother 2016; 60: 2373-82.
5. Crémet L, Bourigault C, Lepelletier D et al. Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. J Antimicrob Chemother 2012; 67: 1041-3.
6. Stein A, Raoult D. Colistin: an antimicrobial for the 21st century? Clin Infect Dis 2002; 35: 901-2.
7. Meletis G, Tzampaz E, Sianou E et al. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother 2011; 66: 946-7.
8. Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 2014; 5: 643.
9. Mitrophanov AY, Jewett MW, Hadley TJ et al. Evolution and dynamics of regulatory architectures controlling polymyxin B resistance in enteric bacteria. PLoS Genet 2008; 4: e1000233.
10. Jayol A, Nordmann P, Brink A et al. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 2015; 59: 2780-4.
11. Napier BA, Band V, Burd EM et al. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob Agents Chemother 2014; 58: 5594-7.
12. Ren Y, Ren Y, Zhou Z et al. Complete genome sequence of Enterobacter cloacae subsp. cloacae type strain ATCC 13047. J Bacteriol 2010; 192: 2463-4.
13. Hoffmann H, Roggenkamp A. Population genetics of the nomenspecies Enterobacter cloacae. Appl Environ Microbiol 2003; 69: 5306-18.
14. Landman D, Salamera J, Quale J. Irreproducible and uninterpretable polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2013; 51: 4106-11.
15. Oliver A, Cantón R, Campo P et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288: 1251-4.
16. El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 2015; 28: 191-207.
17. Lo-Ten-Foe JR, de Smet AM, Diederen BM et al. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007; 51: 3726-30.
18. Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin inmultidrugresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 2946-50.
19. Band VI, Crispell EK, Napier BA et al. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nature Microbiol 2016; doi:10.1038/nmicrobiol.2016.53.
20. Hindler JA, Humphries RM. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 2013; 51: 1678-84.
21. Akbari M, Bakhshi B, Najar Peerayeh S. Particular distribution of Enterobacter cloacae strains isolated from urinary tract infection within clonal complexes. Iran Biomed J 2016; 20: 49-55.
22. Diene SM, Merhej V, Henry M et al. The rhizome of the multidrugresistant Enterobacter aerogenes genome reveals how new "killer bugs" are created because of a sympatric lifestyle. Mol Biol Evol 2013; 30: 369-83.